Skip to main content
VANI
NASDAQ Industrial Applications And Services

Vivani Medical Secures $4.5M Capital Raise, Chairman Invests at Premium

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.38
Mkt Cap
$100.674M
52W Low
$0.905
52W High
$1.92
52W Position info
52% above low
Off High info
28% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

VANI sits 52% above its 52-week low of $0.905.

Summary

Vivani Medical announced a $4.5 million capital raise through a registered direct offering and a concurrent private placement, with Chairman Gregg Williams investing $2.0 million at a price above the current market.


Key Events · Financing and Capital Events · VANI

  • Capital Raise Details

    The company raised approximately $4.5 million in gross proceeds through a registered direct offering of 1,689,200 shares ($2.5 million) and a concurrent private placement of 1,351,351 shares ($2.0 million).

  • Premium Pricing

    Shares in both the registered direct offering and the private placement were priced at $1.48 per share, which is above the current stock price of $1.38.

  • Chairman's Significant Investment

    Gregg Williams, Chairman of the Board, invested $2.0 million in the private placement, demonstrating strong insider confidence. This follows his recent significant share purchase on January 20, 2026.

  • Use of Proceeds

    The net proceeds are intended to fund ongoing research and clinical development of product candidates, as well as for working capital and general corporate purposes.


Analysis · VANI · Industrial Applications And Services

This filing details a crucial capital raise for Vivani Medical, a clinical-stage biopharmaceutical company. The ability to secure $4.5 million in gross proceeds, representing a substantial portion of its market capitalization, is vital for funding ongoing research and clinical development. The pricing of the shares at $1.48, which is above the current market price of $1.38, is a particularly strong positive signal, suggesting institutional confidence in the company's valuation. Furthermore, the significant $2.0 million investment by Chairman Gregg Williams in the concurrent private placement, building on his recent Form 4 purchase on January 20, 2026, underscores a robust vote of confidence from a key insider. This capital infusion provides essential runway for the company's operations and product pipeline advancement.

At the time of this filing, VANI was trading at $1.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $100.7M. The 52-week trading range was $0.91 to $1.92. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VANI - Latest Insights

VANI
Jul 16, 2026, 9:00 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $1.30 info
Change: -$0.110 (-8%) info
Market Cap: $112.106M info
VANI
Jul 16, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $1.30 info
Change: -$0.1339 (-9%) info
Market Cap: $112.106M info
VANI
Jul 07, 2026, 7:46 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $1.30 info
Change: -$0.220 (-14%) info
Market Cap: $112.106M info
VANI
Jul 07, 2026, 7:35 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.42
Real-time Price: $1.30 info
Change: -$0.1202 (-8%) info
Market Cap: $112.106M info
VANI
Jun 30, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $1.30 info
Change: +$0.0597 (+5%) info
Market Cap: $112.106M info